fda approve mdma for ptsd

    Before Jan 1, 2030

    fda approve mdma for ptsd. Best Yes near 56¢ across 1 platform. Live cross-platform prices. Not financial advice.

    Best Yes: 56¢ · Best No: 50¢ · 1 platform

    • Kalshi: Yes 56¢ / No 50¢
    TRADING OPEN

    Before Jan 1, 2030

    Volume

    $2.4K

    $505 24h

    Platforms

    1

    Cross-platform pricing

    Resolution

    Resolves Jan 1, 2030

    ~1205 days left

    Category

    Culture

    56¢CHANCE OF YES53%47%
    Yes
    56¢
    Kalshi
    No
    50¢
    Kalshi

    Opens on best-price platform

    Compare & Trade

    1 platform
    kalshi
    Kalshi
    Best Yes
    Best No
    Yes
    56¢
    No
    50¢
    Vol
    $2.4K
    $505 24h
    Trade on Kalshi

    Price History

    Loading…

    About This Market

    If the FDA approves midomafetamine / MDMA for PTSD for marketing before Jan 1, 2030, then the market resolves to Yes.

    Fee Impact at These Prices

    KalshiKalshiat 56¢: exit costs ~1.72¢/contract
    Full calculator

    Market Details

    ResolutionResolves Jan 1, 2030
    Time Left1205 days
    Status● Active
    CategoryCulture

    Sign in to join the discussion

    Sign In